Clinical Trial

Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis

Study acronym: GLUREDLUP
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The aim of the study is to evaluate the efficacy of a therapeutic regimen which decreases glucocorticoid exposure compared with standard therapy in patients with proliferative lupus nephritis during remission induction by evaluating the histological and clinical remission.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-01-13; most recent amendment 2022-03-02.
Status change: Not Yet Recruiting → Recruiting 2022-03-02
Trial Details
NCT Number NCT05207358
Lead Sponsor Institutul Clinic Fundeni
Conditions Lupus Nephritis
Enrollment 30 participants
Start Date 2022-03-02
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-03-03